[Pharmacokinetics of tolbutamide and glycodiazine in liver and kidney diseases].
作者信息
Held H, Eisert R, von Oldershausen H F
出版信息
Verh Dtsch Ges Inn Med. 1973;79:1220-3.
PMID:4790141
Abstract
摘要
相似文献
1
[Pharmacokinetics of tolbutamide and glycodiazine in liver and kidney diseases].[甲苯磺丁脲和格列本脲在肝脏和肾脏疾病中的药代动力学]
Verh Dtsch Ges Inn Med. 1973;79:1220-3.
2
Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.格列嘧啶（甘氨二嗪）和甲苯磺丁脲在急慢性肝病中的药代动力学
Arzneimittelforschung. 1973 Dec;23(12):1801-7.
3
[On the pharmacokinetics of sulfamethoxypyrazine in chronic liver and kidney diseases].[磺胺甲氧嗪在慢性肝肾疾病中的药代动力学]
Arzneimittelforschung. 1969 Jan;19(1):98-100.
4
[Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].[肝脏疾病、肾功能障碍以及保泰松、苯丙香豆素和强力霉素对甘氨二氮嗪排泄的影响]
Diabetologia. 1970 Aug;6(4):386-91. doi: 10.1007/BF01212070.
5
Influence of some salicylates and sulfonamides on binding by albumin of SPC-703 and tolbutamide.某些水杨酸盐和磺胺类药物对SPC - 703及甲苯磺丁脲与白蛋白结合的影响。
Pol J Pharmacol Pharm. 1976;28(2):129-35.
6
[Changes of pharmacokinetics of oral antidiabetics from drug interference and renal insufficiency].
Dtsch Med Wochenschr. 1970 Dec 11;95(50):2525-7. doi: 10.1055/s-0028-1108869.
7
[Simulation of the biodynamics of glycodiazine with the analog computer].[用模拟计算机对糖二氮嗪生物动力学进行模拟]
Arzneimittelforschung. 1968 Nov;18(11):1443-5.
8
[On 2-benzolsulfonylamino-5(beta-methoxy-ethoxy)-pyrimidine (glycodiazine. V. In vitro and in vivo experiments on the action of phenylethylbarbituric acid (Luminal) on the metabolism and blood sugar reducing effect of glycodiazine].[关于2-苯磺酰氨基-5（β-甲氧基-乙氧基）-嘧啶（糖二氮嗪。V. 苯巴比妥（鲁米那）对糖二氮嗪代谢及降血糖作用的体外和体内实验]
Naunyn Schmiedebergs Arch Pharmakol Exp Pathol. 1966;255(2):200-20.
9
[Spectrofluorometric method for determination of glycodiazine in plasma and of the both glycodiazine metabolites in urine].[血浆中糖二氮嗪及尿中两种糖二氮嗪代谢物的荧光分光光度测定法]
Arzneimittelforschung. 1970 Dec;20(12):1927-9.
Zotero 插件